Cornerstone Robotics Enters New Phase of Global Expansion with CE Mark Approval for Sentire Surgical System

Cornerstone Robotics' Sentire Surgical System Achieves CE Mark Approval

Cornerstone Robotics, a pioneering innovator in surgical robotics based in Hong Kong, has recently announced a significant milestone in its journey toward global healthcare solutions. The Sentire Endoscopic Surgical System has officially received the CE marking under the European Medical Device Regulation (MDR), paving the way for its use in various minimally invasive surgical procedures across multiple fields such as general surgery, gynecology, thoracic surgery, and urology.

Opening Doors to European Markets

This CE certification is more than just a regulatory achievement; it signifies that the Sentire System is now primed for market entry in Europe. This marks a strategic expansion for Cornerstone Robotics, which has been laying the groundwork for a broader presence in the continent since 2025. The company has partnered with the Portsmouth Hospitals University NHS Trust to conduct compliant clinical studies, diligently gathering clinical data that supports evidence-based research, training protocols, and clinical implementation.

During these studies, the Sentire System has been utilized in numerous complex procedures within the UK, focusing on key specializations such as urology, gynecology, and both upper and lower gastrointestinal surgeries. Results have shown promising outcomes for patient care, and medical professionals have expressed high satisfaction regarding the system's performance.